ABSTRACT
OBJECTIVE: To determine if child care centers in rural, Western North Carolina met recommendations for nutrition and physical activity, if focusing on nutrition and physical activity practices and policies was effective in improving the center environment, and if differences existed between centers affiliated or unaffiliated with schools. METHODS: Of 33 child care centers in three counties, 29 submitted mini-grant requests and participated in a pre-post evaluation using Nutrition and Physical Activity Self-Assessment for Child Care (NAP SACC). NAP SACC assesses compliance for nutrition and physical activity recommendations and standards. Between October 2011 and April 2012, centers participated in workshops and goal setting specific to nutrition and physical activity. RESULTS: At baseline, over 95% of the centers met all recommendations. However, post-intervention, Wilcoxon Signed Ranks Test (p<0.05) indicated significant improvement across center types in five out of 37 nutrition and seven out of 17 physical activity standards following the intervention. Centers unaffiliated with schools made significant changes in ten nutrition standards, while those affiliated with schools improved in only two standards and decreased on one standard. CONCLUSION: Overall, rural child care centers in Western North Carolina were meeting standards, they were still able to strengthen policies and practices by following NAP SACC. This was especially true for centers unaffiliated with schools. Continued financial support may assist centers in sustaining increased physical activity in children.
Subject(s)
Child Care/standards , Health Promotion/methods , Motor Activity , Nutrition Policy , Obesity/prevention & control , Animals , Child Day Care Centers , Child, Preschool , Humans , North Carolina , Program Evaluation , Rural Population , Schools , Self-AssessmentABSTRACT
Eruptions in cancer patients may signal life-threatening infections, cutaneous metastases or reactions to chemotherapeutic agents. Distinguishing between these processes is essential to correctly treat the patient. The authors present a patient with a diffuse eruption that was initially believed to be infectious in etiology. Temporal correlation with administration of Taxotere (docetaxel, sanofi aventis, Bridgewater, NJ) as well as histologic and microbiologic data established the eruption as a reaction to this medication. It is important to recognize this eruption (as well as others similar to it). The authors present clinical and histopathologic information to help clinicians identify reactions to this type of chemotherapy.
Subject(s)
Antineoplastic Agents/adverse effects , Drug Eruptions/etiology , Exanthema/chemically induced , Taxoids/adverse effects , Antineoplastic Agents/therapeutic use , Docetaxel , Drug Eruptions/drug therapy , Drug Eruptions/pathology , Exanthema/drug therapy , Exanthema/pathology , Female , Humans , Middle Aged , Taxoids/therapeutic useABSTRACT
Chromhidrosis is a rare but troubling syndrome whose cardinal feature is the appearance of colored sweat. In some instances, this may be associated with the use of drugs or ingested materials [Dermatology vol. 199 (1999) 149-52] but in others it is idiopathic. Irrespective of the etiology, the appearance of colored sweat can be profoundly psychologically disturbing. We report the case of a woman who had been affected by chromhidrosis for several years. Treatment with botulinum toxin type A resulted in a cessation of the problem with profoundly improved quality of life for this individual. This is significant because it is the first case of isolated axillary chromhidrosis treated with botulinum toxin A and, as with reports of facial chromhidrosis [Journal of the American Academy of Dermatology vol. 52 (2005) 89-91], resolution of the symptoms supports the eccrine etiology of this entity.
Subject(s)
Axilla , Botulinum Toxins, Type A/therapeutic use , Sweat Gland Diseases/drug therapy , Axilla/physiopathology , Female , Humans , Middle Aged , Quality of Life/psychology , Sweat Gland Diseases/physiopathologyABSTRACT
Severe scarring acne is frequently treated with isotretinoin. Patients treated with this drug may expect some of the more common complications including mucositis. Less common complications may also occur in a small number of patients. While undergoing treatment, patients may become colonized with Staphylococcus bacteria. However, the incidence of perioral abscess formation in patients taking isotretinoin is not commonly reported and the onset of this adverse event may masquerade as angioedema or severe mucositis.This article presents a case of a significant perioral abscess and discuss the need for prompt recognition as well as treatment of the infection.The case reported is unique due to the extent and severity of the abscess.
